Trabeculation is crucial for cardiac muscle growth in vertebrates. This process requires the Erbb2/4 ligand Neuregulin (Nrg), secreted by the endocardium, as well as blood flow/cardiac contractility. Here, we address two fundamental, yet unresolved, questions about cardiac trabeculation: why does it initially occur in the ventricle and not the atrium, and how is it modulated by blood flow/contractility. Using loss-of-function approaches, we first show that zebrafish Nrg2a is required for trabeculation, and using a protein-trap line, find that it is expressed in both cardiac chambers albeit with different spatiotemporal patterns. Through gain-of-function experiments, we show that atrial cardiomyocytes can also respond to Nrg2a signalling, suggesting that the cardiac jelly, which remains prominent in the atrium, represents a barrier to Erbb2/4 activation. Furthermore, we find that blood flow/contractility is required for Nrg2a expression, and that while non-contractile hearts fail to trabeculate, non-contractile cardiomyocytes are also competent to respond to Nrg2a/Erbb2 signalling. C ardiac trabeculation, which allows the increase in muscle mass prior to the formation of coronaries, is one of the most important processes the vertebrate heart must undergo to form and function properly 1 . During this process, trabeculae, which are sponge-like muscular structures in the cardiac cavity, form as a result of cardiomyocyte delamination and proliferation [2] [3] [4] [5] [6] . Defects in this complex morphogenetic event lead to embryonic lethality or adult onset dilated cardiomyopathy 5, [7] [8] [9] [10] [11] [12] illustrating the importance of trabeculation in cardiac development and function.
C ardiac trabeculation, which allows the increase in muscle mass prior to the formation of coronaries, is one of the most important processes the vertebrate heart must undergo to form and function properly 1 . During this process, trabeculae, which are sponge-like muscular structures in the cardiac cavity, form as a result of cardiomyocyte delamination and proliferation [2] [3] [4] [5] [6] . Defects in this complex morphogenetic event lead to embryonic lethality or adult onset dilated cardiomyopathy 5, [7] [8] [9] [10] [11] [12] illustrating the importance of trabeculation in cardiac development and function.
The vertebrate heart initially consists of two cell layers, the endocardium and myocardium, separated by an acellular, gelatinous matrix called the cardiac jelly [13] [14] [15] . Ablating components of the cardiac jelly by injecting hyaluronidase in chick embryos has been reported to cause looping defects 16 , indicating that it plays an important role during early cardiac morphogenesis. Endocardial-myocardial interactions are known to orchestrate cardiac trabeculation; for example, in chick embryos, a myocardial-derived growth factor, Angiopoietin 1, has been reported to bind to its receptor Tie2 which is expressed by endocardial cells and modify their angiogenic behaviour which in turn affects the complexity of cardiac trabeculation 17 . Similarly, signalling from endocardial to myocardial cells is also necessary for trabeculation. For instance, mice lacking the endocardial-derived ligand Nrg1 or its receptors Erbb2 and Erbb4, which are expressed by myocardial cells, exhibit severe trabeculation defects 7, 8, 12, 18 . Similarly, zebrafish erbb2 mutants fail to form trabeculae 5 . Additional studies have shown that Nrg signalling can positively regulate cardiomyocyte proliferation and heart regeneration [19] [20] [21] [22] .
Cardiac formation can also be influenced by its function [23] [24] [25] . Recent studies have shown the dependence of trabeculation on physical forces generated by cardiac contractility and blood flow 6, 26, 27 . For instance, several groups have reported that reduction of blood flow in the ventricular chamber markedly diminishes trabeculation in chick embryos and zebrafish larvae 6, 26, 28, 29 . By manipulating cardiac contractility, another study presented data indicating that cardiac contraction promotes trabeculation through the regulation of Notch signalling in the ventricular endocardium 27 . These and other findings support the hypothesis that physical forces are necessary in the developing heart, particularly during trabecular formation.
In this study, we use the zebrafish model to address two fundamental questions pertinent to cardiac trabeculation; first, why trabeculae initially form in the ventricle and not the atrium, as is observed in zebrafish as well as in other vertebrates including amniotes 3, 30 , and second, how trabeculation is modulated by physical forces. Using a genetic approach and high-resolution live imaging, we first show that Nrg2a is an essential ligand for cardiac trabeculation in zebrafish. By ectopically expressing nrg2a in cardiomyocytes, we further show that atrial cardiomyocytes, like ventricular cardiomyocytes, can respond to Nrg2a/Erbb2 signalling. Using loss-and gain-of-function approaches, we show that blood flow/contractility modulates endocardial nrg2a expression while it is not required for the expression or function of Nrg2a/Erbb2 signalling effectors in cardiomyocytes.
Results
Nrg2a is required for cardiac trabeculation in zebrafish. Given the role of Nrg1 in cardiac trabeculation in mouse 7, 8, 12, 18 , we mutated zebrafish nrg1 using TALEN technology 31 . Since nrg1 has multiple isoforms 32 , we targeted exon 2 which encodes part of the highly conserved IGc2-domain, and identified a D14 allele ( Supplementary Fig. 1a ) encoding a predicted truncated protein ( Supplementary Fig. 1b ) due to harbouring a premature stop codon within the same exon. Using brightfield microscopy, no gross morphological defects were observed in nrg1 D14 (nrg1 bns101 ) homozygous mutant larvae ( Supplementary Fig. 1c,d ). Incrossing nrg1 bns101/ þ fish in the Tg(myl7:LIFEACT-GFP) background, a myocardial specific line in which F-actin (filamentous actin) is labelled with GFP 33 , we observed that trabeculation appears unaffected in nrg1 bns101 mutant larvae ( Supplementary Fig. 1e-h ), which can survive to become fertile adults.
Next, we decided to investigate the role of Nrg2a, another member of the Nrg family, by using a conditional protein-trap line, nrg2a mn0237Gt (refs 34,35) . Using brightfield microscopy, nrg2a mutants can be recognized by their aberrant jaws (Fig. 1a,b) as well as other defects in median fin fold (MFF) morphogenesis and swim bladder inflation 35 . As previously reported, the gene-breaking transgene (GBT) nrg2a allele generates a truncated Nrg2a protein tagged with mRFP (Nrg2a-mRFP) due to the in-frame integration of the mutagenic pGBT-RP2.1 (RP2) cassette in the intron between alternative exon 1C and exon 2 (ref. 35 ). Prior studies have also shown that the expression of Nrg2a-mRFP recapitulates that of endogenous nrg2a (refs 34,35) . Confocal imaging of larvae from nrg2a þ / À incrosses in the Tg(myl7:LIFEACT-GFP) background (Fig. 1c-k) revealed that Nrg2a-mRFP is highly expressed in the endocardium at early larval stages (Fig. 1d ,e,g,h,j,k), and that nrg2a À / À hearts fail to form trabeculae by 75 h post fertilization (hpf) (Fig. 1c-e) . Observation of nrg2a mutants at later stages, including 120 and 168 hpf ( Fig. 1f-k) , confirmed that their trabeculation defects appear as severe as those in erbb2 mutants 5 . Overall, these data suggest that Nrg2a, and not Nrg1, is the crucial regulator of cardiac trabeculation in zebrafish.
Differential Nrg2a expression in the ventricle and atrium. Trabeculae start to form in zebrafish around 60 hpf and become clearly apparent by 72 hpf 5, 26 . To investigate why trabeculation occurs primarily in the ventricle and not the atrium 3,30 , we examined Nrg2a-mRFP expression at several stages of cardiac development. We used high-resolution confocal microscopy to image live nrg2a þ / À animals in the Tg(kdrl:NLS-EGFP) background, in which the endothelial cell nuclei are labelled with GFP 36 , at 52, 78 and 120 hpf (Fig. 2a-i ). Nrg2a-mRFP expression appears in the endocardium at 52 hpf, particularly in the outer curvature of the ventricle (Fig. 2a-c , Supplementary  Fig. 2a-c and Fig. 3a-c) . Subsequently, Nrg2a-mRFP expression becomes stronger in ventricular and atrial endocardial cells (Fig. 2d-i, Supplementary Fig. 2d-i, Fig. 3d-i) , although it is weaker in the atrioventricular (AV) canal (Fig. 2d-i and Supplementary Fig. 4a-c) . Accordingly, nrg2a mutants develop functional AV valve leaflets ( Supplementary Fig. 4d-i) as was observed in erbb2 mutants 5 , suggesting that Nrg2a/Erbb2 signalling is not required for AV valve development.
Utilizing the Zeiss Efficient Navigation (ZEN) software, we measured the levels of Nrg2a-mRFP expression as well as the number of Nrg2a-mRFP positive endocardial cells at 78 hpf (Fig. 2j,k) . These analyses show that ventricular endocardial cells express higher levels of Nrg2a-mRFP than atrial or AV canal endocardial cells (Fig. 2j) , and that there are more Nrg2a-mRFP positive endocardial cells in the ventricle as compared to the other cardiac regions (Fig. 2k) . We also found that on average (N ¼ 5 hearts), 97% and 90% of endocardial cells in the ventricle and atrium were positive for Nrg2a-mRFP expression, respectively ( Supplementary Fig. 2j ). Thus, ventricular cardiomyocytes might be exposed to a higher level of Nrg2a ligands than atrial ones, although atrial endocardial cells are clearly positive for Nrg2a-mRFP expression.
To examine whether the Nrg2a protein-trap expression in the endocardium accurately recapitulates endogenous nrg2a expression 34, 35 , we carried out in situ hybridizations on 78 hpf hearts. We observed that nrg2a is more highly expressed in the ventricle, compared to the atrium, and that it is mainly restricted to the outer curvature ( Supplementary Fig. 2k ). This expression pattern is consistent with that of Nrg2a-mRFP.
The cardiac jelly and the onset of trabeculation. The cardiac jelly is known to be pivotal in endo-myocardial interactions required for cardiac morphogenesis 4, 37 , and its reduction during development has previously been reported in chicken and mice 4, 38 . Using high-resolution confocal microscopy, we decided to investigate more closely the dynamics of cardiac jelly reduction around the onset of trabeculation in Tg(kdrl:Hsa.HRAS-mCherry) 39 ;Tg(myl7:EGFP-Hsa.HRAS) 40 animals in which endocardial and myocardial membranes are labelled in red and green, respectively. We found that at 48 hpf the cardiac jelly fully separates the endocardial and myocardial layers (Fig. 3a) , and that its thickness gradually decreases in both chambers but more clearly in the ventricle (Fig. 3b-h ). The timing of this decrease correlates with the appearance of the first trabeculae in the outer curvature of the ventricle by 60 hpf (Fig. 3b,c, arrowhead) . By 96 hpf, the cardiac jelly appears to be fully gone in the ventricle while it remains in the atrium for at least the first 6 days of development ( Fig. 3d-h ).
To investigate whether Nrg2a signalling modulates the thickness of the cardiac jelly, we incrossed nrg2a þ / À animals in the Tg(kdrl:Hsa.HRAS-mCherry);Tg(myl7:LIFEACT-GFP) background, and found no obvious differences between wild types and mutants ( Supplementary Fig. 5a-h) , similar to what we observed in nrg1 bns101 mutants and Erbb2 inhibitor-treated animals ( Supplementary Fig. 5i -k), suggesting that Nrg/Erbb2 signalling is not involved in this process in zebrafish.
Altogether, these data show that the reduction of the cardiac jelly takes place in the ventricle as trabeculation starts, suggesting that it may determine the onset of this process, possibly by constituting a diffusion barrier for Nrg ligands. nrg2a overexpression in cardiomyocytes. The current model is that endocardial-derived Nrg ligands traverse the cardiac jelly to activate cardiomyocyte behaviour and proliferation 4, 12, 41, 42 . To determine whether ectopic overexpression of nrg2a in cardiomyocytes enables them to form trabeculae in nrg2a mutants, we collected embryos from Tg(myl7:LIFEACT-GFP);nrg2a þ / À incrosses and injected them with a myl7:nrg2a-p2a-tdTomato plasmid at the one-cell stage (Fig. 4a,b) . This approach allows one to identify the nrg2a overexpressing cardiomyocytes by virtue of their expression of tdTomato. Confocal microscopy analysis showed that ectopic overexpression of nrg2a in nrg2a mutant ventricular cardiomyocytes could drive them to form a multilayered wall in most tdTomato positive hearts (13o15) (Fig. 4c-e) . To determine whether Nrg2a signals via Erbb2 in cardiomyocytes, we ectopically overexpressed nrg2a in erbb2 st61 mutant cardiomyocytes. Our results show that mosaic myocardial nrg2a overexpression did not rescue the trabeculation defects in erbb2 mutants (Fig. 4f-i) , indicating that Nrg2a must signal through Erbb2 in cardiomyocytes.
We also generated a stable myocardial-specific Nrg2a transgenic line by injecting wild-type embryos with the myl7:nrg2a-p2a-tdTomato plasmid. Although a majority of the injected animals survived to adulthood, some exhibited pericardial edema due to the presence of a much enlarged heart as compared to those of non-injected animals, indicating that mosaic expression of nrg2a in cardiomyocytes leads to cardiomegaly ( Supplementary Fig. 6a-d) , as expected from data in mouse using a transgene encoding constitutively active Erbb2 (ref. 21 ) and in zebrafish using nrg1 overexpression 22 . Overall, these data indicate that ventricular cardiomyocytes are capable to respond to the myocardial overexpression of nrg2a.
Atrial cardiomyocytes can respond to Nrg2a signalling. To further investigate the correlation between cardiac jelly thickness and the onset of trabeculation, we used our newly generated Tg(myl7:nrg2a-p2a-tdTomato) line to evaluate the behaviour of cardiomyocytes in the presence or absence of Nrg2a signalling (Fig. 5a ). The cardiac jelly is present for at least the first 6 days of development in the zebrafish atrium, physically separating the endocardial and myocardial walls (Fig. 3) , and thus possibly preventing myocardial cells from receiving endocardial-derived Nrg2a molecules. A myocardial specific nrg2a overexpression approach allows one to circumvent the hypothetical barrier function of the cardiac jelly and test whether atrial cardiomyocytes are in fact competent to respond to Nrg signalling. To better visualize cardiomyocyte boundaries, Tg(myl7:nrg2a-p2a-tdTomato) fish were outcrossed to the myocardial specific membrane line Tg(myl7:EGFP-Hsa.HRAS). Compared to Tg(myl7:nrg2a-p2a-tdTomato) negative animals, we observed that nrg2a overexpression in cardiomyocytes pushed them to form a bilayered wall in the ventricle as well as the atrium starting at 46 and 78 hpf, respectively (Fig. 5b-e , Supplementary  Fig. 7a,b) . Subsequently, constitutively active Nrg2a signalling resulted in cardiomyocyte multilayering in both ventricular and atrial walls ( Fig. 5f-i) . However, this cardiomyocyte response was blocked by Erbb2 inhibitor treatment starting at 36 hpf ( Supplementary Fig. 8a-d) . By crossing the Tg(myl7:nrg2a-p2a-tdTomato) line with a Fucci line (Tg(myl7:mVenus-gmnn)) which labels proliferating cardiomyocytes in green 43 , we observed that ectopic myocardial expression of nrg2a increased the number of proliferating cardiomyocytes ( Supplementary Fig. 9a-f) . Overall, these data indicate that both ventricular and atrial cardiomyocytes can respond to Nrg/Erbb2 signalling. ;nrg2a À / À hearts injected with myocardial specific nrg2a construct (myl7:nrg2a-p2a-tdTomato) at the one-cell stage. Mosaic overexpression of nrg2a in nrg2a À / À cardiomyocytes led to the formation of a multilayered myocardial wall which is outlined by a white dashed box and magnified (c-e); arrows point to nrg2a overexpressing cardiomyocytes. (f-i) Confocal images (mid-sagittal sections) of 120 hpf Tg(myl7:EGFP-Hsa.HRAS) hearts from erbb2 þ / À incrosses injected with the myl7:nrg2a-p2a-tdTomato construct (h-i). Magnified images of dashed boxes are shown below c-i; arrows point to nrg2a overexpressing cardiomyocytes, arrowheads point to trabeculae and asterisks indicate lack of trabeculae. At, atrium; V, ventricle; scale bars, 50 mm.
nrg2a protein-trap line, we wanted to investigate how cardiac contractility/blood flow regulates nrg2a expression in the zebrafish heart. At 78 hpf, we observed that endocardial Nrg2a-mRFP is strongly expressed in the outer curvature of wild-type ventricles, where trabeculae are present, while it is clearly weaker in other endocardial cells (Fig. 6a-c,j) . The levels of Nrg2a-mRFP expression in the heart were strongly reduced in the absence of cardiac contractility in tnnt2a morphants 44 ( Fig. 6d-f ,k) and 2,3-butanedione monoxime (BDM)-treated larvae (Fig. 6g-i,l) , indicating that contraction and/or blood flow is required for cardiac expression of Nrg2a-mRFP. To investigate whether there is also a role for cardiac contractility in regulating Erbb2 downstream signalling pathways, we injected Tg(myl7:EGFPHas.HRAS);Tg(myl7:nrg2a-202-p2a-tdTomato) embryos with tnnt2a morpholinos and imaged them by confocal microscopy at 78 hpf. Notably, we observed that myocardial overexpression of nrg2a resulted in cardiomyocyte multilayering even in the absence of contractility (Fig. 6m,n) . However, overexpressing nrg2a throughout the endothelium, including the endocardium, by using a stable Tg(fli1a:nrg2a-p2a-tdtomato) line did not cause a cardiomyocyte multilayering phenotype in tnnt2a morphants ( Supplementary Fig. 10 ). By injecting low amount of myl7:nrg2a-p2a-tdTomato plasmid DNA in tnnt2a morphants, we also observed that mosaic expression of nrg2a recruits both nrg2a expressing and non-expressing cardiomyocytes to form a multilayered wall suggesting that nrg2a affects the behaviour of cardiomyocytes via both autocrine and paracrine signals ( Supplementary Fig. 11 ). Furthermore, it has been recently reported that N-cadherin relocalizes to the basal side of cardiomyocytes during trabeculation 45 . We observed that nrg2a overexpression in non-contractile cardiomyocytes was sufficient to drive the relocalization of Cdh2-EGFP molecules to their basal side (Fig. 6o-r, Supplementary Movie 1) while they remained mostly localized on the lateral sides of non-nrg2a expressing cardiomyocytes, further indicating that cardiac contraction is not necessary for cardiomyocytes to respond to Nrg2a signalling. Altogether, these results support a model in which contractility/blood flow is required for endocardial expression of nrg2a but not the expression or function of Nrg2a/Erbb2 signalling effectors (Fig. 6s) .
Discussion
During trabeculation, cardiomyocytes undergo several morphogenetic changes required for the luminal growth and maintenance of the myocardial wall 2, 5, 6, 8, 33, 43, 45 . Taking advantage of high-resolution live imaging in the translucent zebrafish larvae, we investigated, using loss-and gain-of-function approaches, why trabeculation takes place primarily in the ventricle and how it is controlled by cardiac contractility/blood flow. Given the importance of Nrg1 in cardiac trabeculation in mouse 11, 46, 47 , we investigated the role of Nrg1 in zebrafish and found that it is not required for trabeculation, a finding consistent with a very recent publication 48 . Instead we found that Nrg2a is required for trabeculation in zebrafish while loss of Nrg2 does not lead to any obvious cardiac defects in mouse 49 . Nrg signalling plays many essential roles in vertebrate development and homeostasis 5, 12, 41, 50, 51 , and it will be interesting to investigate ligand selection across evolutionary time. We also observed that Nrg1 and Nrg2a signalling are not required for AV valve formation in zebrafish, consistent with previous observations of erbb2 mutants 5 . In mouse, Erbb2-Erbb3 heterodimer activity is required for early AV valve formation 52, 53 , and it will be interesting to investigate the role of Erbb3 in zebrafish heart development.
To investigate why trabeculae form only in the ventricle, we used the nrg2a mn0237Gt/ þ protein-trap line 35 to monitor the endogenous expression of nrg2a, and found that it is expressed in the endocardium similar to mouse Nrg1 and Nrg2 (refs 54,55). Our results also indicate that Nrg2a-mRFP is strongly expressed in endocardial cells lining the outer curvature of the ventricle whereas it is weaker in other endocardial cells suggesting that some ventricular cardiomyocytes might be exposed to higher level of Nrg2a signalling. One caveat here of course is that we examined the expression of a fusion protein which is likely to have very different stability than the endogenous Nrg2a protein.
Prior studies have also revealed the critical role of the cardiac jelly in endo-myocardial interactions 16, 56, 57 . Investigating the dynamics of cardiac jelly degradation during early cardiac development, we observed that by the time trabeculae appear, little cardiac jelly is left in the ventricle. By ectopic myocardial overexpression of nrg2a, we found that atrial cardiomyocytes could also respond to Nrg2a/Erbb2 signalling. We speculate that atrial cardiomyocytes receive less Nrg ligands, which are expressed by endocardial cells, due to the thickness of the cardiac jelly in the atrium and consequently do not form a multilayered wall.
When we overexpressed nrg2a in cardiomyocytes using the myl7 promoter, we observed the formation of multiple continuous layers rather than the formation of trabeculae, possibly because of the high levels, even distribution and premature expression of nrg2a. We hypothesize that the expression of lower levels of nrg2a in single cardiomyocytes starting at the right stage would lead them to delaminate and seed trabeculae as observed in wild-type embryos, and new transgenic tools will be required to test this hypothesis. In addition, higher levels of Nrg2a signalling might drive cardiomyocyte proliferation.
Several groups have shown the importance of physical forces in cardiac morphogenesis 6, 24, 27, 58, 59 . It has recently been reported that in zebrafish cardiac contraction is required for cardiac nrg1 expression but not for cardiac erbb2 expression 27 . Here, we showed that contractility/blood flow is essential for cardiac expression of nrg2a. Interestingly, although nrg1 upregulation by broad expression of a Notch intracellular domain was not sufficient to rescue trabeculation defects in tnnt2a morphants 27 , we could induce cardiomyocyte multilayering in these animals by myocardial overexpression of nrg2a. Moreover, we also showed that ectopic overexpression of nrg2a in non-contractile cardiomyocytes led to the relocalization of Cdh2-EGFP to their basal side. Overall, these data indicate that contractility/blood flow is indispensable for cardiac expression of nrg2a but not the ability of cardiomyocytes to respond to nrg2a.
We also observed that unlike myocardial specific nrg2a overexpression, endocardial specific nrg2a overexpression did not induce cardiomyocyte multilayering in tnnt2a morphants, likely due to the presence of a substantial gap between the endocardial and myocardial layers. These data further suggest that the thickness of the cardiac jelly may play an important role in determining when trabeculation starts.
In conclusion, our data indicate that trabeculae may initially form only in the ventricle in part because the cardiac jelly in the atrium does not get degraded as fast as it does in the ventricle. Atrial cardiomyocytes exhibit another kind of behaviour as they form the inner pectinate myofibers 60, 61 , and it will be interesting to investigate the underlying signalling pathways. We also found that biomechanical forces work upstream of Nrg2a/Erbb2 signalling to modulate trabeculation in the zebrafish heart by modulating nrg2a expression in the endocardium. It will be important to identify the proteins involved in sensing these forces as well as the transcriptional effectors regulating nrg2a expression.
Methods
Zebrafish husbandry. Embryonic and adult zebrafish were raised and maintained under standard conditions 62 and all animal experiments were done according to German Animal Protection Laws approved by the local governmental animal protection committee. Generation of nrg1 bns101 mutant. nrg1 mutants were generated by TALEN mutagenesis targeting exon 2. The following TALEN arms were constructed and assembled using the Golden Gate method 31 An amount of 100 pg of total TALEN RNA and 50 pg of GFP RNA (used to monitor injection efficiency) were coinjected into the cell at the one-cell stage.
The nrg1 bns101 allele was genotyped using high-resolution melt analysis (HRMA) with an Eco Real-Time PCR System (Illumina).
The following HRMA primers were used for PCR reactions:
Mosaic and stable overexpression of nrg2a. To generate a myocardial specific nrg2a overexpressing construct, the nrg2a-202 coding sequence followed by p2a-tdTomato was cloned in a mini tol2 plasmid harbouring a myl7 promoter using the Cold Fusion Cloning Kit (MC101A-1-SB). For mosaic expression of nrg2a, 15 pg of myl7:nrg2a-202-p2a-tdTomato plasmid DNA was coinjected with 10 ng of Tol2 RNA into the cell at the one-cell stage.
To establish the Tg(myl7:nrg2a202-p2a-Tomato) bns140 line, injected larvae (F0) were screened for myocardial tdTomato fluorescence and raised to adulthood. NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15281 ARTICLE After identifying founders, F1 embryos positive for fluorescence in their cardiomyocyte were raised to adulthood.
Morpholino injections.
To stop cardiac contraction, 0.5 ng of a tnnt2a morpholino (5 0 -CATGTTTGCTCTGATCTGACACGCA-3 0 ) was injected into one-cell stage embryos 44 .
Chemical treatments. To prevent contractility for 6 h (short term treatment), 72 hpf zebrafish larvae were exposed to 20 mM BDM 65 . To block Erbb2 signalling, dechorionated embryos were treated with 10 mM of the Erbb2 inhibitor PD 168393 (Calbiochem) from 36 to 96 hpf.
In vivo confocal imaging and data processing. Zebrafish embryos and larvae were mounted and anesthetized in 1.5% low-melt agarose (Sigma) containing 0.2 per cent tricaine on glass-bottom dishes. Before the gel solidified, the samples were manually oriented towards the microscope lens to enhance optical access to the heart. Images were captured with a Zeiss LSM780 or a spinning disk (CSU-X1 Yokogawa) confocal microscope using Â 40 (1.1 NA) and Â 40 (1.15 NA) water immersion lenses, respectively. The confocal data were then processed with the ZEN 2012 software (black edition). Nrg2a-mRFP intensity per cell was measured with the ZEN 2012 software (blue edition).
Whole mount in situ hybridization. To perform whole mount in situ hybridization 66 , 78 hpf zebrafish larvae were fixed in 4% paraformaldehyde overnight at 4°C and subsequently dehydrated in 100% methanol at À 20°C. Larvae were rehydrated with 1 Â PBS and permeabilized by digestion with proteinase K (10 mg ml À 1 ) at room temperature for 30 min. After washing with 1 Â PBT (1 Â phosphate buffered saline (PBS), 0.1% Tween 20 (vol/vol)), larvae were hybridized with 200 ng of nrg2a antisense DIG-labelled RNA probe overnight at 70°C. The hybridized probes were then detected with alkaline phosphataseconjugated anti-Digoxigenin antibody (Roche, dilution 1:1,000) for three hours at room temperature and the signal was visualized with BM purple (Roche).
The probe for nrg2a was amplified from 78 hpf heart cDNA using nrg2a forward 5 0 -TCTGTGTGGCTCTTTTGGTG-3 0 and reverse 5 0 -GTGCGTC AGTCTGGTCTGTG-3 0 primers. The PCR fragment was subcloned into pGEM-T.
Statistical analysis. Data were processed with the Prism5 software. Values are presented as mean±s.e. P values (*Pr0.05, **Pr0.01, ***Pr0.001) were calculated using Student's t-test.
Data availability. The authors declare that all data supporting the findings of this study are available within the article and its Supplementary Information files or from the corresponding author upon reasonable request.
